Eligibility criteria for Sacubitril-Valsartan in patients admitted for heart failure: the real world

被引：0
|
作者：
David Cabrita Roque, D. [1 ]
Augusto, J. [1 ]
Santos, M. [1 ]
Candeias Faria, D. [1 ]
Baltazar Ferreira, J. [1 ]
Sacchetti, A. [2 ]
Melo, L. [2 ]
Oliveira Soares, A. [1 ]
Morais, C. [1 ]
机构：
[1] Hosp Prof Fernando Fonseca EPE, Cardiol, Amadora, Portugal
[2] Hosp Prof Fernando Fonseca EPE, Internal Med, Amadora, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1859
引用
收藏
页码：477 / 478
页数：2
相关论文
共 50 条
  • [21] Real world experience with sacubitril/valsartan in heart failure
    Lim, E. L. S.
    Abdullah, E. L.
    Loh, L. C. W.
    Chong, P. F.
    Sia, H. P.
    Sothivadivel, S.
    Lee, J. L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [22] Age-based comparison of patients with heart failure treated with sacubitril-valsartan in France: a real-world evaluation
    Hanon, O.
    Cohen, A.
    Jourdain, P.
    Leray, E.
    De Pouvourville, G.
    Dheyriat, L.
    Hugon, G.
    Logeart, D.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] Sacubitril-valsartan prescription during heart failure hospitalization: real-world initial experience.
    Morillas Climent, H.
    Galcera Jornet, E.
    Alania Torres, E.
    Seller Moya, J.
    Vicedo Lopez, A.
    Rodriguez Pichardo, Y.
    Larumbe Rodriguez, A.
    Valle Munoz, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 309 - 309
  • [24] Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
    Del Buono, Marco Giuseppe
    Bonaventura, Aldo
    Vecchie, Alessandra
    Wohlford, George F.
    Dixon, Dave L.
    Van Tassel, Benjamin W.
    Abbate, Antonio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (02) : 105 - 107
  • [25] Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure
    Cacciatore, Francesco
    Amarelli, Cristiano
    Maiello, Ciro
    Pratillo, Mariella
    Tosini, Piera
    Mattucci, Irene
    Salerno, Gemma
    Curcio, Francesco
    Elia, Francesco
    Mercurio, Valentina
    Golino, Paolo
    Bonaduce, Domenico
    Abete, Pasquale
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 272 : 132 - 137
  • [26] What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
    Pellicori, Pierpaolo
    Urbinati, Alessia
    Shah, Parin
    MacNamara, Alexandra
    Kazmi, Syed
    Dierckx, Riet
    Zhang, Jufen
    Cleland, John G. F.
    Clark, Andrew L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 768 - 778
  • [27] Safety and efficacy of sacubitril-valsartan in acute heart failure
    Le Bras, Alexandra
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (01) : 4 - 4
  • [28] The safety of sacubitril-valsartan for the treatment of chronic heart failure
    Tyler, Jeffrey M.
    Teerlink, John R.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 257 - 263
  • [29] Sacubitril-Valsartan for the Treatment of Heart Failure Effectiveness and Value
    Ollendorf, Daniel A.
    Sandhu, Alexander T.
    Pearson, Steven D.
    JAMA INTERNAL MEDICINE, 2016, 176 (02) : 249 - 250
  • [30] SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
    Cooper, Lauren Beth
    Kaltenbach, Lisa
    Al-Khalidi, Hussein
    Cole, Robert
    Allen, Larry A.
    Fonarow, Gregg C.
    Butler, Javed
    Albert, Nancy M.
    Lanfear, David E.
    Granger, Bradi
    Kociol, Robb
    Pina, Ileana
    Heidenreich, Paul
    Granger, Christopher B.
    Felker, G. Michael
    Lewis, Eldrin
    McRae, Andrew
    Hernandez, Adrian
    DeVore, Adam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1063 - 1063
12345